Drug Interactions between abacavir and Reyataz
This report displays the potential drug interactions for the following 2 drugs:
- Reyataz (atazanavir)
Interactions between your drugs
No interactions were found between abacavir and Reyataz. This does not necessarily mean no interactions exist. Always consult your healthcare provider.
- Abacavir is in the drug class nucleoside reverse transcriptase inhibitors (NRTIs).
- Abacavir is used to treat the following conditions:
- Reyataz is in the drug class protease inhibitors.
- Reyataz is used to treat the following conditions:
Drug and food interactions
Applies to: Reyataz (atazanavir)
Food can enhance the levels of atazanavir in your body. To ensure maximal oral absorption, atazanavir should be administered with or immediately after a meal. This will make it easier for your body to absorb the medication.
Therapeutic duplication warnings
No warnings were found for your selected drugs.
Therapeutic duplication warnings are only returned when drugs within the same group exceed the recommended therapeutic duplication maximum.
Drug Interaction Classification
|Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit.|
|Moderately clinically significant. Usually avoid combinations; use it only under special circumstances.|
|Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan.|
|No interaction information available.|
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.